miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma
Carcinogenesis · 2023
DOI: 10.1093/carcin/bgad055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2023. Verfasst von Shukai Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, 22 Qixiangtai Road, Heping District, …. Hauptthemen laut MEDLINE: MicroRNAs, STAT3 Transcription Factor, Skin Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipal Science and Technology Commission, Tianjin First Central Hospital.
Abstract (Originalsprache)
Immunotherapy is the only approved systemic therapy for advanced cutaneous squamous cell carcinoma (cSCC), however, roughly 50% of patients do not respond to the therapy and resistance often occurs over time to those who initially respond. Immunosuppression could have a critical role in developing treatment resistance, thus, understanding the mechanisms of how immunosuppression is developed and regulated may be the key to improving clinical diagnosis and treatment strategies for cSCC. Here, through using a series of immunocompetent genetically engineered mouse models, we demonstrate that miR-22 promotes cSCC development by establishing regulatory T cells (Tregs)-mediated immunosuppressive tumor microenvironment (TME) in a tumor cell autonomous manner. Mechanism investigation revealed that miR-22 elicits the constitutive activation of JAK/STAT3 signaling by directly targeting its suppressor SOCS3, which augments cancer cell-derived chemokine secretion and Tregs recruitment. Epithelial-specific and global knockouts of miR-22 repress papilloma and cSCC development and progression, manifested with reduced Tregs infiltration and elevated CD8+ T cell activation. Transcriptomic analysis and functional rescue study confirmed CCL17, CCL20 and CCL22 as the main affected chemokines that mediate the chemotaxis between miR-22 highly expressing keratinocyte tumor cells and Tregs. Conversely, overexpression of SOCS3 reversed miR-22-induced Tregs recruitment toward tumor cells. Clinically, gradually increasing Tregs infiltration during cSCC progression was negatively correlated with SOCS3 abundance, supported by previously documented elevated miR-22 levels. Thus, our study uncovers a novel miR-22–SOCS3–JAK/STAT3–chemokines regulatory mechanism in defining the immunosuppressive TME and highlights the promising clinical application value of miR-22 as a common targeting molecule against JAK/STAT3 signaling and immune escape in cSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, 22 Qixiangtai Road, Heping District, Tianjin 300070, China.
- Department of General Surgery, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
- School of Basic Medicine, Xinxiang Medical University, Xinxiang 453003, China.
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin 300052, China.
- Neurosurgical Department, Tianjin First Central Hospital, No. 24 Fukang Road, Nankai District, Tianjin 300192, China.
ORCID-Profile: Li Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin Municipal Science and Technology Commission
- Tianjin First Central Hospital
- Central Universities
Zitieren
APA
Yuan, S., Zhu, T., Wang, J., Jiang, R., Shu, A., Zhang, Z., Zhang, P., Feng, X., & Zhao, L. (2023). miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma. Carcinogenesis. https://doi.org/10.1093/carcin/bgad055
Vancouver
Yuan S, Zhu T, Wang J, Jiang R, Shu A, Zhang Z, et al. miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma. Carcinogenesis. 2023. doi:10.1093/carcin/bgad055
BibTeX
@article{Yuan2023,
author = {Yuan, Shukai and Zhu, Tong and Wang, Jianan and Jiang, Ruoyu and Shu, Aofeng and Zhang, Zhenlei and Zhang, Peitao and Feng, Xuequan and Zhao, Li},
title = {miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma},
journal = {Carcinogenesis},
year = {2023},
doi = {10.1093/carcin/bgad055}
}
EUVIMED